| Application no. and date | 17857371.3 (espacenet) (Federated) (European Patent Register), 20170927 | | Patent/reg. no. and date | DK/EP 3518911, 20210825 | | Publication date | 20190807 | | Priority no. and date | US 201662400495 P, 20160927 | | EP pub. no. and date |
EP 3518911 20190807 | | Effective date | | | Applicant/owner | Radius Pharmaceuticals, Inc., 22 Boston Wharf Road, 7th Floor
Boston, MA 02210, US | | Applicant ref. no. | HONQ/P68575EP | | Inventor | HATTERSLEY, Gary, 14 Woodman Drive
Stow
MA 01775, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/337 (2006.01) , A61K 31/506 (2006.01) , A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) , C07C 217/84 (2006.01) | | Title | RAD1901 FOR USE IN TREATING OVARIAN CANCER | | Int. application no. | US2017053834 | | Int. publication no. | WO2018064231 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
